Ticker Scorecard - IMUX Basics Company: Immunic, Inc. IPO Date: April 14, 2014 Sector: Healthcare Industry: Biotech Market Cap: $85.58M Activated in VL: True Average Daily Range Avg Daily Range: $0.29 | 3.99% Avg Daily Range (30 D): $0.03 | 2.47% Avg Daily Range (90 D): $0.04 | 3.02% Institutional Daily Volume Avg Daily Volume: .56M Avg Daily Volume (30 D): .95M Avg Daily Volume (90 D): .84M Trade Size Avg Trade Size (Sh.): 184 Avg Trade Size (Sh.) (30 D): 472 Avg Trade Size (Sh.) (90 D): 318 Institutional Trades Total Inst.Trades: 84 Avg Inst. Trade: $2.1M Avg Inst. Trade (30 D): $1.87M Avg Inst. Trade (90 D): $1.76M Avg Inst. Trade Volume: .35M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $2.64M Avg Closing Trade (30 D): $.51M Avg Closing Trade (90 D): $.51M Avg Closing Volume: 345.3K     News Feb 29, 2024 @ 3:40 PM Immunic And 2 Other Stocks Under $2 Insiders Are B... Source: Avi Kapoor Oct 10, 2023 @ 5:08 PM Why Startek Shares Are Trading Higher By 29%? Here... Source: Lisa Levin Oct 10, 2023 @ 12:19 PM Why Immunic Shares Are Trading Higher By Around 13... Source: Lisa Levin Apr 6, 2023 @ 6:10 PM Immunic's (IMUX) Ulcerative Colitis Study Shows Po... Source: Zacks Equity Research Apr 5, 2023 @ 5:33 PM Why Kura Sushi Shares Are Trading Lower By Around ... Source: Lisa Levin Financials   TTM Q2 2024 Q1 2024 Basic EPS $-.24 $-.21 $-.3 Diluted EPS $-.24 $-.21 $-.3 Revenue $ M $ M $ M Gross Profit $ $ $ Net Income / Loss $ -24.37M $ -21.38M $ -29.58M Operating Income / Loss $ -25.73M $ -22.81M $ -23.88M Cost of Revenue $ $ $ Net Cash Flow $ -20.63M $ -17.61M $ 50.64M PE Ratio     Splits Apr 15, 2019:   40:1